Comparison of ultra-slow, voltage-dependent inactivation of the cardiac L-type Ca2+ channel with Ca2+ or Ba2+ as the charge carrier in ferret ventricular myocytes

Exp Physiol. 1996 Jul;81(4):565-75. doi: 10.1113/expphysiol.1996.sp003959.

Abstract

The whole-cell patch clamp technique was used to investigate the effect of different charge carriers upon ultra-slow voltage-dependent inactivation of L-type Ca2+ channel current in ferret ventricular myocytes at 37 degrees C. Intracellular Ca2+ was buffered with 10 mM EGTA and the membrane potential held at -40 mV. With Ba2+ as the charge carrier, the L-type current decayed throughout 20 s pulses to 0 mV as a result of ultra-slow voltage-dependent inactivation. In contrast, with Ca2+ as the charge carrier, there was no such slow decay of the current as the current decayed almost completely in the first approximately 100 ms as a result of Ca(2+)-dependent inactivation. However, with Ca2+ as the charge carrier it is still possible that ultra-slow voltage-dependent inactivation occurs. A conditioning-test pulse protocol and a second protocol were used to test for the development of ultra-slow inactivation during 20 or 30 s pulses to 0 mV with Ca2+ as the charge carrier. Ultra-slow inactivation did occur and it was qualitatively similar to that with Ba2+ as the charge carrier. The onset of ultra-slow inactivation with Ca2+ as the charge carrier could be described by the sum of two exponentials with time constants of 0.3 and 6.7 s. Recovery from ultra-slow inactivation with Ca2+ as the charge carrier was also measured with a conditioning-test pulse protocol and was best described by the sum of two exponentials with time constants of 0.5 and 6.2 s. We conclude that ultra-slow inactivation of the L-type current does occur with the physiological charge carrier, Ca2+, but it is normally masked by Ca(2+)-dependent inactivation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Barium / pharmacology*
  • Calcium / pharmacology*
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism*
  • Female
  • Ferrets / metabolism*
  • Heart Ventricles / cytology
  • Heart Ventricles / drug effects
  • Heart Ventricles / metabolism
  • In Vitro Techniques
  • Male
  • Myocardium / cytology
  • Myocardium / metabolism*
  • Patch-Clamp Techniques

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Barium
  • Calcium